Jane Moseley

European regulators’ views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials

Marion Haberkamp, Jane Moseley, Dimitrios Athanasiou et al. · Neuromuscular Disorders · 2019 · 64 citations · Full text

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice

Giovanni Tafuri, Margherita Pagnini, Jane Moseley et al. · British Journal of Clinical Pharmacology · 2016 · 63 citations · Full text

Impact Analysis of Signals Detected from Spontaneous Adverse Drug Reaction Reporting Data

Patrick Waller, Emma Heeley, Jane Moseley · Drug Safety · 2005 · 43 citations

Drug Safety, Drug Hypersensitivity, Impact Analysis +12

The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment recommendations

Giovanni Tafuri, Inês Lucas, Steve Estevão et al. · British Journal of Clinical Pharmacology · 2018 · 37 citations · Full text

Development of a Retinopathy of Prematurity Activity Scale and Clinical Outcome Measures for Use in Clinical Trials

Lois E. H. Smith, Ann Hellström, Andreas Stahl et al. · JAMA Ophthalmology · 2018 · 24 citations